EU Approves First Biologic for Severe Uncontrolled Asthma
Tezspire is the first and only biologic approved in the EU for patients with severe asthma with no phenotype or biomarker limitations.
Medscape Medical News
source https://www.medscape.com/viewarticle/981382?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/981382?src=rss
Comments
Post a Comment